Innobiochips SAS

Founded in 2008 in France, Innobiochips is a pioneering biotechnology company specializing in high-definition multiplex analysis. Alongside our flagship Omnys product line, we offer dedicated, tailor-made services to meet diverse analytical challenges.Our breakthrough solutions are designed for a wide range of advanced applications, including Active Pharmaceutical Ingredient applications, antibody clone screening, large-scale population screening, and complex sample information correlation.

The Omnys Ecosystem
Our flagship Omnys ecosystem integrates a compact reader, dedicated data analysis software, a smart rotor, and proprietary biochips, revolutionizing laboratory workflows. Thanks to our cutting-edge technology, laboratories can achieve complete extended phenotyping and dozens of simultaneous results from a single micro-drop of sample.

• MULTIPLY LAB PRODUCTIVITY BY 4:

Micro-volume requirements preserve precious biological material. Omnys enables the complete characterization of a blood unit using only 4 to 6 wells, integrating seamlessly into current workflows while significantly reducing manipulation steps and hands-on time.

• 57% REDUCTION IN CARBON EMISSIONS

Omnys dramatically reduces the amount of infectious lab waste and plastic required to perform blood tests, simultaneously lowering transportation costs and your overall environmental impact.

• ENLARGE SAMPLE CHARACTERIZATION

Benefit from high-definition multiplexing for comprehensive, standardized data. Move to the next generation of blood typing and ensure maximum donor and patient compatibility with complementary data and embedded controls at no additional cost.